Carmell Co. (NASDAQ:CTCX – Get Free Report) was the recipient of a significant increase in short interest in October. As of October 15th, there was short interest totalling 391,200 shares, an increase of 968.9% from the September 30th total of 36,600 shares. Approximately 2.9% of the company’s stock are short sold. Based on an average daily volume of 4,500,000 shares, the short-interest ratio is currently 0.1 days.
Carmell Price Performance
CTCX remained flat at $0.35 on Friday. The company’s stock had a trading volume of 549,899 shares, compared to its average volume of 1,467,444. The company has a 50-day simple moving average of $0.48 and a two-hundred day simple moving average of $1.35. Carmell has a 52 week low of $0.29 and a 52 week high of $4.31.
Carmell (NASDAQ:CTCX – Get Free Report) last announced its earnings results on Wednesday, August 14th. The company reported ($0.16) earnings per share for the quarter. The company had revenue of $0.01 million during the quarter.
Institutional Investors Weigh In On Carmell
About Carmell
Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.
Featured Articles
- Five stocks we like better than Carmell
- Market Cap Calculator: How to Calculate Market Cap
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- The 3 Best Retail Stocks to Shop for in August
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- Energy and Oil Stocks Explained
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Carmell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carmell and related companies with MarketBeat.com's FREE daily email newsletter.